Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 117.50
-0.50 (-0.42%)
At close: Mar 27, 2026
Bioteque Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 539.19 | 528.26 | 452.55 | 493.54 | 431.26 |
Depreciation & Amortization | 171.55 | 162.86 | 155.96 | 131.63 | 122.2 |
Loss (Gain) From Sale of Assets | - | 5.94 | 0.06 | - | - |
Loss (Gain) From Sale of Investments | 1.79 | -5.44 | -3.16 | -9.65 | 2.91 |
Other Operating Activities | 3 | 32.6 | 2.16 | 25.35 | -18.11 |
Change in Accounts Receivable | -51.03 | -0.98 | 20.84 | 8.52 | 3.51 |
Change in Inventory | 26.34 | -26.06 | 37.07 | -16.8 | -49.77 |
Change in Accounts Payable | -7.96 | -22.25 | 1.49 | -21.43 | 72.01 |
Change in Unearned Revenue | -9.8 | 19.46 | -6.89 | 16.84 | -28.8 |
Change in Other Net Operating Assets | -8.88 | 8.24 | 19.3 | 16.57 | -65.97 |
Operating Cash Flow | 664.2 | 702.62 | 679.38 | 644.58 | 469.25 |
Operating Cash Flow Growth | -5.47% | 3.42% | 5.40% | 37.36% | -26.05% |
Capital Expenditures | -57.2 | -98.13 | -72.76 | -726.83 | -550.87 |
Sale of Property, Plant & Equipment | - | - | 0.08 | - | - |
Investment in Securities | -149.05 | -143.25 | 41.99 | 198.82 | -149.79 |
Other Investing Activities | -8.81 | -100.74 | -24.84 | -51.82 | 147.88 |
Investing Cash Flow | -215.06 | -342.12 | -55.52 | -579.83 | -552.77 |
Short-Term Debt Issued | 90 | 30 | 70.51 | - | 84.03 |
Long-Term Debt Issued | - | - | 101.11 | 446 | 120.9 |
Total Debt Issued | 90 | 30 | 171.62 | 446 | 204.93 |
Short-Term Debt Repaid | -90 | -30 | -72.29 | -28.56 | -55.52 |
Long-Term Debt Repaid | -164.08 | -161.18 | -88.92 | -31.51 | -13.57 |
Total Debt Repaid | -254.08 | -191.18 | -161.21 | -60.07 | -69.09 |
Net Debt Issued (Repaid) | -164.08 | -161.18 | 10.42 | 385.93 | 135.84 |
Common Dividends Paid | -346.49 | -311.84 | -311.84 | -311.84 | -277.19 |
Other Financing Activities | -7.52 | -9.99 | -9.94 | -5.32 | -91.3 |
Financing Cash Flow | -518.09 | -483.01 | -311.37 | 68.77 | -232.65 |
Foreign Exchange Rate Adjustments | -7.36 | 5.65 | 24.03 | 11.17 | -4.79 |
Net Cash Flow | -76.31 | -116.86 | 336.52 | 144.69 | -320.96 |
Free Cash Flow | 607 | 604.49 | 606.62 | -82.25 | -81.63 |
Free Cash Flow Growth | 0.41% | -0.35% | - | - | - |
Free Cash Flow Margin | 28.43% | 29.17% | 31.19% | -4.09% | -4.47% |
Free Cash Flow Per Share | 8.71 | 8.68 | 8.71 | -1.18 | -1.17 |
Cash Interest Paid | 7.61 | 10.07 | 11.73 | 5.32 | 3.6 |
Cash Income Tax Paid | 139.5 | 126.86 | 126.48 | 108.16 | 127.01 |
Levered Free Cash Flow | 464.19 | 352.83 | 459.47 | -237.49 | -8.47 |
Unlevered Free Cash Flow | 468.9 | 358.69 | 466.72 | -234.8 | -7.29 |
Change in Working Capital | -51.32 | -21.6 | 71.81 | 3.7 | -69.01 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.